{"title": "Preformulation study of a Cuban pentavalent DPT-HB-Hib vaccine, Heberpenta\u00ae-L", "author": "N\u00e9stor S Exp\u00f3sito-Raya; Yayr\u00ed C Prieto-Correa; Mabel Izquierdo-L\u00f3pez; Zoe Nuez-Lamothe; Soraya Piloto-D\u00edaz; Yamila Mart\u00ednez-Cuellar; Makis Torres-Toledo; Annette Pereira-Sanabria; Rub\u00e9n L\u00f3pez-Edghill; Jose L Marcelo-Sainz; Amarilys Rodriguez-Arrebato; Mar\u00eda de los A Denis-Cruz; Yanet Alderete-Avalos; Anaelsi Chacon-Molina; Eduardo Mart\u00ednez-D\u00edaz", "url": null, "hostname": null, "description": null, "sitename": "Biotecnolog\u00eda Aplicada", "date": "1999-01-01", "cleaned_text": "2020, Number 1 Biotecnol Apl 2020; 37 (1) Preformulation Kb. of combined vaccines is a very useful project for all the advantages that this type of vaccine provides. However, complexities in its execution due to their technological challenges make difficult its development. In this sense, the pentavalent vaccine (DPT-HB-Hib), branded as Heberpenta\u00ae, has technology were studied using different physical-chemical and biological tests. The technology for the formulation of the pentavalent vaccine produced in Cuba was defined to OE, Szymanski Zahn M, et al. vaccines is associated T, Hessel L, Schmitt HJ, von Kries R. of WM, Klein NP. Kinrix: A new combination DTaPIPV aged 46 years. Expert experience. Am other EP 0835663B1. 1993 May 15. Jones LTS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effects of adsorption to aluminum salt on production control combined toxin-antitoxine dipht\u00e9riques. CR Soc Biol. 1922;86:6. World Health Organization. Manual for the Production and Control of Vaccines: Tetanus Toxoid. Geneva: WHO; 1978. Gonz\u00e1lez-Griego A, Ram\u00edrez V, Salgado A, Vingut JL. Cuantificaci\u00f3n del ant\u00edgeno de superficie del VHB (HBsAg) en muestras biol\u00f3gicas con fines asistenciales y preparativos. Apl. 1993;10(2):10. British Pharmacopoeia. London: Her Pharmacopoeia Convention; Inc.: Rockville, MD; 2007. PPO 4.09.064.92. Determinaci\u00f3n de concentraci\u00f3n de i\u00f3n aluminio por Complejometr\u00eda. La Habana: CIGB; 1999. CIGB. PPO 4.09.062.92. Espectrofotometr\u00eda m\u00e9todo utilizado por el fabricante (CIGB) para la cuantificaci\u00f3n de Tiomersal en las vacunas monovalentes y combinadas. La Habana: CIGB; 1992. BioCen. PNO 07.154, Determinaci\u00f3n de la toxicidad espec\u00edfica de las dift\u00e9rica y tet\u00e1nica en BioCen. la toxicidad la en la vacuna pentavalente DPT-HB-Hib, Heberpenta-L. La Habana: BioCen; 2009. Gonz\u00e1lez P, Mart\u00ednez S, Ram\u00edrez JC, Dom\u00ednguez F, D\u00edaz Y, Ram\u00edrez U, et al. Vacuna antidift\u00e9rica-tet\u00e1nica y antidift\u00e9ricatet\u00e1nica- pertussis: evaluaci\u00f3n del producto final. VacciMonitor. 1999;8(2):8-12. CIGB. PPO.4.09.093.04. Procedimiento para la determinaci\u00f3n de la identidad del AgsHB utilizando el sistema ELISA en vacunas. La Habana: CIGB; 2013. CIGB. PPO.4.09.041.03. Procedimiento para la determinaci\u00f3n de la identidad del PRP-T utilizando el m\u00e9todo de inmunoidentificaci\u00f3n por Latex en vacunas. La Habana: CIGB; 2008. Fitzgerald EA. Overview of the methods for potency testing of diphtheria and tetanus toxoids in the United States. In: Manclark CR (ed). Proceedings of an Informal Consultation on the World Health Organization Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines. Department of Health and Human Services, United States Public Health Service. Bethesda, MD, DHHS Publication No. (FDA) 91-1174; 1991. pp 61-4. Finney D J. Probit Analysis. 3rd edition. New York: Cambridge University Press; 1971. World Health Organization. Manual of laboratory methods for testing of vaccines used in the WHO PPO 4.09.060.92. Edici\u00f3n 09. Procedimiento establecido para la determinaci\u00f3n de la potencia in vivo de la vacuna la hepatitis B recombinante y vacunas combinadas que contengan como componente activo el AgsHB. La Habana: CIGB; 2008. CIGB. PPO 4.09.037.03. Procedimiento para la determinaci\u00f3n de la inmunogenicidad del componente PRP-T en vacunas. La Habana: and In: Woodrow GC, (eds), New Generation Vaccines. New York: Marcel Dekker; 1990. pp. 251. Latham WC, Bent DF, Levine L. Tetanus toxin of protein. Appl Environ Microbiol. 1962;10(2): 146-52. Organizaci\u00f3n Mundial de la Salud. Gu\u00eda de la OMS sobre los requisitos de las pr\u00e1cticas adecuadas de fabricaci\u00f3n (PAF). Segunda parte: Validaci\u00f3n. WHO/ magnetic resonance study of adsorption solution interface. Langmuir. 1991;7:1702-12. Iyer Robinett RS, HogenEsch H, Hem SL. Mechanism of depolymerisation in the presence Gilchrist M Jr. Bordetella. Manual of clinical microbiology, 5th ed. Washington "}